It has been reported that the activation of AMPK plays an essential role in the protection of hepatic steatosis by suppressing ACC activity via phosphorylation for the inhibitory effect of fatty acid synthesis, and inhibiting both the transcriptional activity and the expression of SREBP-1c and its target lipogenesis genes. Here, SREBF1 is linked to Hepatic steatosis.